PAX7 and breast carcinoma: Similarly, while in vitro experiments showed that PAX7 knockdown inhibited breast cancer cell proliferation, migration, and invasion, these experiments were performed in limited cell lines, and the heterogeneity of breast cancer requires validation across different molecular subtypes.